Compositional modelling of immune response and virus transmission dynamics.
COVID-19
epidemics
immune response
multi-scale modelling
process calculi
Journal
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences
ISSN: 1471-2962
Titre abrégé: Philos Trans A Math Phys Eng Sci
Pays: England
ID NLM: 101133385
Informations de publication
Date de publication:
03 Oct 2022
03 Oct 2022
Historique:
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
17
8
2022
Statut:
ppublish
Résumé
Transmission models for infectious diseases are typically formulated in terms of dynamics between individuals or groups with processes such as disease progression or recovery for each individual captured phenomenologically, without reference to underlying biological processes. Furthermore, the construction of these models is often monolithic: they do not allow one to readily modify the processes involved or include the new ones, or to combine models at different scales. We show how to construct a simple model of immune response to a respiratory virus and a model of transmission using an easily modifiable set of rules allowing further refining and merging the two models together. The immune response model reproduces the expected response curve of PCR testing for COVID-19 and implies a long-tailed distribution of infectiousness reflective of individual heterogeneity. This immune response model, when combined with a transmission model, reproduces the previously reported shift in the population distribution of viral loads along an epidemic trajectory. This article is part of the theme issue 'Technical challenges of modelling real-life epidemics and examples of overcoming these'.
Identifiants
pubmed: 35965463
doi: 10.1098/rsta.2021.0307
pmc: PMC9376723
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20210307Subventions
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V027956/1
Pays : United Kingdom
Références
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Nat Biotechnol. 2009 Dec;27(12):1099-102
pubmed: 20010584
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D689-91
pubmed: 16381960
J Integr Bioinform. 2020 Jul 24;17(2-3):
pubmed: 32759406
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
Bioinformatics. 2009 Mar 1;25(5):687-9
pubmed: 19147665
PLoS Comput Biol. 2010 May 27;6(5):e1000793
pubmed: 20523740
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Theor Biol. 2021 Dec 7;530:110851
pubmed: 34343578
Mol Syst Biol. 2020 Aug;16(8):e9110
pubmed: 32845085
Bioinformatics. 2008 Sep 15;24(18):2122-3
pubmed: 18658182
Elife. 2021 Feb 23;10:
pubmed: 33620317
Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):
pubmed: 26150668
Lancet. 2020 Jul 25;396(10246):e6-e7
pubmed: 32653078
Pharm Res. 2009 Nov;26(11):2369-400
pubmed: 19756975
J Virol. 2010 Apr;84(8):3974-83
pubmed: 20130053
Bioinformatics. 2018 Jul 1;34(13):i583-i592
pubmed: 29950016
BMJ. 2020 Oct 23;371:m3862
pubmed: 33097561
J Virol. 2010 Jul;84(13):6687-98
pubmed: 20410284
Curr Opin Virol. 2021 Oct;50:103-109
pubmed: 34450519
Science. 1950 Jan 13;111(2872):23-9
pubmed: 15398815
Science. 2021 Jul 16;373(6552):
pubmed: 34083451
J Infect. 2020 Sep;81(3):357-371
pubmed: 32615199
J Virol. 2006 Aug;80(15):7590-9
pubmed: 16840338
Bioinformatics. 2003 Mar 1;19(4):524-31
pubmed: 12611808
PLoS Comput Biol. 2021 Jul 26;17(7):e1009149
pubmed: 34310589
J Biol Dyn. 2017 Dec;11(1):378-435
pubmed: 28849734
J Exp Med. 2017 May 1;214(5):1259-1267
pubmed: 28363897